SAN

81.67

-0.97%↓

MRK1

119.65

-0.17%↓

SHL.DE

44.82

+1.11%↑

ARGX

725.4

-1.17%↓

FRE

48.51

+0.37%↑

SAN

81.67

-0.97%↓

MRK1

119.65

-0.17%↓

SHL.DE

44.82

+1.11%↑

ARGX

725.4

-1.17%↓

FRE

48.51

+0.37%↑

SAN

81.67

-0.97%↓

MRK1

119.65

-0.17%↓

SHL.DE

44.82

+1.11%↑

ARGX

725.4

-1.17%↓

FRE

48.51

+0.37%↑

SAN

81.67

-0.97%↓

MRK1

119.65

-0.17%↓

SHL.DE

44.82

+1.11%↑

ARGX

725.4

-1.17%↓

FRE

48.51

+0.37%↑

SAN

81.67

-0.97%↓

MRK1

119.65

-0.17%↓

SHL.DE

44.82

+1.11%↑

ARGX

725.4

-1.17%↓

FRE

48.51

+0.37%↑

Strona główna・Stock List・Vetoquinol SA

Vetoquinol SA

Closed

SectorHealthcare

81.2 2.92

Buy Sell

Overview

Share price change

24h

Current

Min

79.1

Max

82.6

Key metrics
By Trading Economics
Income	-9.8M 25M
Sales	-17M 258M
P/E Sector Avg	15.235 76.798
Dividend yield	1.16
Profit margin	9.734
Employees	2,497
EBITDA	-12M 48M

Dividends
By Dow Jones
Dividend yield Sector Avg	1.16% 2.37%
Next Earnings	19 mar 2026

Market Stats
By TradingEconomics
Market Cap	9.7M 919M
Previous open	78.28
Previous close	81.2

News Sentiment

By Acuity

25%

75%

56 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

72.6 / 75.1 Support & Resistance

Vetoquinol SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

22 gru 2025, 23:54 UTC

Major Market Movers

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

22 gru 2025, 19:08 UTC

Acquisitions, Mergers, Takeovers

Correction to Alphabet to Buy Intersect Article

22 gru 2025, 17:21 UTC

Acquisitions, Mergers, Takeovers

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

22 gru 2025, 16:46 UTC

Acquisitions, Mergers, Takeovers

Alphabet to Buy Intersect for $4.75 Billion in Cash

22 gru 2025, 23:50 UTC

Market Talk

Nikkei May Decline as Yen Rebounds -- Market Talk

22 gru 2025, 23:42 UTC

Market Talk

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

22 gru 2025, 22:31 UTC

Earnings

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

22 gru 2025, 22:31 UTC

Earnings

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

22 gru 2025, 22:30 UTC

Earnings

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

22 gru 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 gru 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

22 gru 2025, 21:37 UTC

Acquisitions, Mergers, Takeovers

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

22 gru 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

22 gru 2025, 21:35 UTC

Acquisitions, Mergers, Takeovers

Capricorn to Acquire Prospective Package From Tempest Minerals

22 gru 2025, 21:35 UTC

Acquisitions, Mergers, Takeovers

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

22 gru 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

Middle West Partners Buys Paul Stuart From Mitsui & Co.

22 gru 2025, 20:52 UTC

Acquisitions, Mergers, Takeovers

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

22 gru 2025, 20:09 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

22 gru 2025, 19:56 UTC

Market Talk

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

22 gru 2025, 19:49 UTC

Acquisitions, Mergers, Takeovers

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

22 gru 2025, 19:23 UTC

Market Talk

Mexico's Inflation Seen Easing in Early December -- Market Talk

22 gru 2025, 19:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 gru 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

22 gru 2025, 19:02 UTC

Market Talk

Precious Metals Climb to New Heights -- Market Talk

22 gru 2025, 18:45 UTC

Market Talk

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

22 gru 2025, 18:30 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

22 gru 2025, 18:23 UTC

Acquisitions, Mergers, Takeovers

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

22 gru 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

22 gru 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

22 gru 2025, 17:06 UTC

Acquisitions, Mergers, Takeovers

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Peer Comparison

Price change

Vetoquinol SA Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Vetoquinol SA - Dist in the past 3 months.

Technical Score

By Trading Central

72.6 / 75.1Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

56 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.